Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great research interest. mRNA vaccines are a potential choice for tumor immunotherapy, due to their ability to directly encode anti...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2024-02-01
|
| Серія: | Vaccines |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2076-393X/12/2/186 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|